7 results on '"Marseglia, G."'
Search Results
2. Pediatric health care professionals' vaccine knowledge, awareness and attitude: a survey within the Italian Society of Pediatric Allergy and Immunology.
- Author
-
Del Duca, Elisabetta, Chini, Loredana, Graziani, Simona, Sgrulletti, Mayla, Moschese, Viviana, with the Italian Pediatric Immunology and Allergology Society (SIAIP) Vaccine Committee, Moschese, V., Chini, L., Sgrulletti, M., Dellepiane, R. M., Martire, B., Sangerardi, M., Montin, D., Ottaviano, G., Rizzo, C., Duse, M., and Marseglia, G.
- Subjects
VACCINATION ,INFLUENZA vaccines ,PROFESSIONS ,IMMUNIZATION ,CONFIDENCE ,ATTITUDE (Psychology) ,MEDICAL personnel ,PEDIATRICS ,PNEUMOCOCCAL vaccines ,QUESTIONNAIRES ,PEDIATRIC nursing ,DESCRIPTIVE statistics ,ROTAVIRUS vaccines ,HERPES zoster vaccines ,NURSE practitioners - Abstract
Background: Physicians play a key role in driving vaccine acceptance and their recommendations are crucial to address vaccine hesitancy. The aim of the study was to assess knowledge, awareness and attitude of Italian Pediatric Health Care Professionals (pHCPs) on vaccinations. Methods: An anonymous on-line questionnaire was developed within the Vaccine Committee of Italian Society of Pediatric Allergy and Immunology (SIAIP) and spontaneously completed by 231 Pediatricians and Pediatric Nurses (PN). Results: An accurate vaccine education was reported by 70% of pediatricians and 13% of PN but 11% of pediatricians versus 26% of PN consult social media instead of scientific sources for their vaccine update. The investigation on the pHCPs attitudes to vaccination in a personal and family setting highlights poor adherence to vaccinations. Only 63% of pediatricians versus 16% of PN (p < 0.0001) annually received the Flu vaccine. In their family setting 93% of pediatricians versus 51% of PN recommended all vaccinations (p < 0.0001). Anti-flu, anti-rotavirus, anti-zoster and anti-pneumococcal vaccines were not regularly recommended by all pHCPs due to doubts of uselessness (55% of pediatricians versus 40% of PN) and preference for "natural immunity" (44% of pediatricians versus 40% of PN). Conclusions: Our results indicate that pHCPs' attitude and confidence in regards to vaccines remain suboptimal. Current COVID-19 pandemic and the rapid development of vaccines could increase vaccine hesitancy. Due to the documented pHCPs' influence in the parental decision, educational interventions are needed to improve their level of knowledge and counselling skills in order to address parental vaccine hesitancy and to maintain continuity of immunization services. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Prevention of recurrent respiratory infections
- Author
-
Katia Perruccio, Giulia Trippella, Martina Ciarcià, Paolo Becherucci, Alberto Villani, Marco Zecca, Valeria Caldarelli, Sergio Bottero, Maria Laura Panatta, Diego Peroni, Giuseppe Di Mauro, Angela Pasinato, Lorenzo Pignataro, Sofia D’Elios, Diletta Valentini, Maurizio de Martino, Guido Morbin, Fabio Cardinale, Vito Leonardo Miniello, Massimo Pifferi, Luciana Indinnimeo, Luisa Galli, Marco Antonio Motisi, Francesca Santamaria, Gian Luigi Marseglia, Francesco Macrì, Chiara Tersigni, Anna Teresa Palamara, Michele Miraglia Del Giudice, Guido Castelli Gattinara, Paolo Biasci, Emanuela Sitzia, Renato Cutrera, Elena Chiappini, Andrea Lo Vecchio, Roberto Mattina, Daniele Ciofi, Claudio Vicini, Sandro Valentini, Paola Marchisio, Attilio Varricchio, Mattia Doria, Sara Torretta, Irene Trambusti, Andrea Novelli, Barbara Bortone, Giorgio Piacentini, Maria Carmen Verga, Sara Antonini, Chiappini, E., Santamaria, F., Marseglia, G. L., Marchisio, P., Galli, L., Cutrera, R., de Martino, M., Antonini, S., Becherucci, P., Biasci, P., Bortone, B., Bottero, S., Caldarelli, V., Cardinale, F., Gattinara, G. C., Ciarcia, M., Ciofi, D., D'Elios, S., Di Mauro, G., Doria, M., Indinnimeo, L., Lo Vecchio, A., Macri, F., Mattina, R., Miniello, V. L., del Giudice, M. M., Morbin, G., Motisi, M. A., Novelli, A., Palamara, A. T., Panatta, M. L., Pasinato, A., Peroni, D., Perruccio, K., Piacentini, G., Pifferi, M., Pignataro, L., Sitzia, E., Tersigni, C., Torretta, S., Trambusti, I., Trippella, G., Valentini, D., Valentini, S., Varricchio, A., Verga, M. C., Vicini, C., Zecca, M., and Villani, A.
- Subjects
Pneumococcal Vaccine ,Complementary Therapies ,medicine.medical_specialty ,Prebiotic ,Review ,Probiotic ,Recurrent respiratory infection ,Antioxidants ,Adenoidectomy ,Pneumococcal Vaccines ,Adjuvants, Immunologic ,Quality of life ,Recurrence ,medicine ,Antibiotic Prophylaxi ,Respiratory Tract Infection ,Humans ,Recurrent respiratory infections ,Thiazolidine ,Hyaluronic Acid ,Child ,Intensive care medicine ,Respiratory Tract Infections ,Children ,Administration, Intranasal ,Tonsillectomy ,Maternal and child health ,business.industry ,Probiotics ,Prevention ,Vitamins ,Antibiotic Prophylaxis ,Settore MED/38 ,Complete resolution ,Pyrrolidonecarboxylic Acid ,Algorithm ,Prebiotics ,Immune system ,Complementary Therapie ,Influenza Vaccines ,Resveratrol ,Thiazolidines ,Antioxidant ,Influenza Vaccine ,business ,Algorithms ,Human - Abstract
Recurrent respiratory infections (RRIs) are a common clinical condition in children, in fact about 25% of children under 1 year and 6% of children during the first 6 years of life have RRIs. In most cases, infections occur with mild clinical manifestations and the frequency of episodes tends to decrease over time with a complete resolution by 12 years of age. However, RRIs significantly reduce child and family quality of life and lead to significant medical and social costs. Despite the importance of this condition, there is currently no agreed definition of the term RRIs in the literature, especially concerning the frequency and type of infectious episodes to be considered. The aim of this consensus document is to propose an updated definition and provide recommendations with the intent of guiding the physician in the complex process of diagnosis, management and prevention of RRIs. Supplementary Information The online version contains supplementary material available at 10.1186/s13052-021-01150-0.
- Published
- 2021
4. Adolescent gender dysphoria management: position paper from the Italian Academy of Pediatrics, the Italian Society of Pediatrics, the Italian Society for Pediatric Endocrinology and Diabetes, the Italian Society of Adolescent Medicine and the Italian Society of Child and Adolescent Neuropsychiatry.
- Author
-
Calcaterra V, Tornese G, Zuccotti G, Staiano A, Cherubini V, Gaudino R, Fazzi EM, Barbi E, Chiarelli F, Corsello G, Esposito SMR, Ferrara P, Iughetti L, Laforgia N, Maghnie M, Marseglia G, Perilongo G, Pettoello-Mantovani M, Ruggieri M, Russo G, Salerno M, Striano P, Valerio G, and Wasniewska M
- Subjects
- Humans, Child, Adolescent, Male, Female, Gender Identity, Italy, Adolescent Medicine, Gender Dysphoria therapy, Neuropsychiatry, Diabetes Mellitus
- Abstract
Background: In response to the imperative need for standardized support for adolescent Gender Dysphoria (GD), the Italian Academy of Pediatrics, in collaboration with the Italian Society of Pediatrics, the Italian Society for Pediatric Endocrinology and Diabetes, Italian Society of Adolescent Medicine and Italian Society of Child and Adolescent Neuropsychiatry is drafting a position paper. The purpose of this paper is to convey the author's opinion on the topic, offering foundational information on potential aspects of gender-affirming care and emphasizing the care and protection of children and adolescents with GD., Main Body: Recognizing that adolescents may choose interventions based on their unique needs and goals and understanding that every individual within this group has a distinct trajectory, it is crucial to ensure that each one is welcomed and supported. The approach to managing individuals with GD is a multi-stage process involving a multidisciplinary team throughout all phases. Decisions regarding treatment should be reached collaboratively by healthcare professionals and the family, while considering the unique needs and circumstances of the individual and be guided by scientific evidence rather than biases or ideologies. Politicians and high court judges should address discrimination based on gender identity in legislation and support service development that aligns with the needs of young people. It is essential to establish accredited multidisciplinary centers equipped with the requisite skills and experience to effectively manage adolescents with GD, thereby ensuring the delivery of high-quality care., Conclusion: Maintaining an evidence-based approach is essential to safeguard the well-being of transgender and gender diverse adolescents., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
5. Present and future are getting confused: are we equipped to face the technological revolution?
- Author
-
Perilongo G, Agostiniani R, Corsello G, Marseglia G, Muraca M, Staiano AM, Zuccotti G, and Baraldi E
- Subjects
- Humans, Italy, Forecasting, Technology
- Abstract
Background: This is a commentary reporting the outcome of a workshop promoted by the Department of Woman's and Child's Health of the University of Padua (Italy) focused on the emerging issue of what seems to be the increasing agemone role of technology., Main Body: Over the centuries, technology has always been at the service of science, with theoretical insights anticipating experimental proofs. Over the last decades, however, the situation has radically changed, due to several factors. Technology seems to be playing an agemone role. The present and notably the future generation of scientists have major challenges to face. They have to deal with the forces generated by the infosphera; to dominate the technology and to maintain the capacity of generating inquisitive, creative, ethical and spiritual thoughts capable of addressing new scientific hypotheses and projects directed to the individual and collective good. However, in this scenario, what seems more relevant is to focus all our efforts in preparing ourselves, first, and then the new generations to face these challenges. From this point of view, the academic institutions and the scientific societies, have a major responsibility to deal with., Conclusions: The academic ecosystem traditionally used to educate the new generation of professionals as well as, and most importantly, the cultural, the professional pathways presently used to form them need to be extensively revised. The time is running short and the stakes are high. The debate is open., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
6. Correction: Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases.
- Author
-
Duse M, Santamaria F, Verga MC, Bergamini M, Simeone G, Leonardi L, Tezza G, Bianchi A, Capuano A, Cardinale F, Cerimoniale G, Landi M, Malventano M, Tosca M, Varricchio A, Zicari AM, Alfaro C, Barberi S, Becherucci P, Bernardini R, Biasci P, Caffarelli C, Caldarelli V, Capristo C, Castronuovo S, Chiappini E, Cutrera R, De Castro G, De Franciscis L, Decimo F, Iacono ID, Diaferio L, Di Cicco ME, Di Mauro C, Di Mauro C, Di Mauro D, Di Mauro F, Di Mauro G, Doria M, Falsaperla R, Ferraro V, Fanos V, Galli E, Ghiglioni DG, Indinnimeo L, Kantar A, Lamborghini A, Licari A, Lubrano R, Luciani S, Macrì F, Marseglia G, Martelli AG, Masini L, Midulla F, Minasi D, Miniello VL, Del Giudice MM, Morandini SR, Nardini G, Nocerino A, Novembre E, Pajno GB, Paravati F, Piacentini G, Piersantelli C, Pozzobon G, Ricci G, Spanevello V, Turra R, Zanconato S, Borrelli M, Villani A, Corsello G, Di Mauro G, and Peroni D
- Published
- 2022
- Full Text
- View/download PDF
7. Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement.
- Author
-
Lanari M, Venturini E, Pierantoni L, Stera G, Castelli Gattinara G, Esposito SMR, Favilli S, Franzoni E, Fusco E, Lionetti P, Maffeis C, Marseglia G, Massella L, Midulla F, Zanobini A, Zecca M, Villani A, Staiano A, and Galli L
- Subjects
- Adolescent, Age Factors, COVID-19 complications, Child, Consensus, Drug Combinations, Humans, Italy, Risk Factors, Societies, Medical, Antibodies, Monoclonal therapeutic use, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Neutralizing therapeutic use, Antiviral Agents therapeutic use, Patient Selection, COVID-19 Drug Treatment
- Abstract
The fast diffusion of the SARS-CoV-2 pandemic have called for an equally rapid evolution of the therapeutic options.The Human recombinant monoclonal antibodies (mAbs) have recently been approved by the Food and Drug Administration (FDA) and by the Italian Medicines Agency (AIFA) in subjects aged ≥12 with SARS-CoV-2 infection and specific risk factors.Currently the indications are specific for the use of two different mAbs combination: Bamlanivimab+Etesevimab (produced by Eli Lilly) and Casirivimab+Imdevimab (produced by Regeneron).These drugs have shown favorable effects in adult patients in the initial phase of infection, whereas to date few data are available on their use in children.AIFA criteria derived from the existing literature which reports an increased risk of severe COVID-19 in children with comorbidities. However, the studies analyzing the determinants for progression to severe disease are mainly monocentric, with limited numbers and reporting mostly generic risk categories.Thus, the Italian Society of Pediatrics invited its affiliated Scientific Societies to produce a Consensus document based on the revision of the criteria proposed by AIFA in light of the most recent literature and experts' agreement.This Consensus tries to detail which patients actually have the risk to develop severe disease, analyzing the most common comorbidities in children, in order to detail the indications for mAbs administration and to guide the clinicians in identifying eligible patients., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.